A Phase 4 interventional study of mycophenolate mofetil [CellCept] and mycophenolate mofetil [CellCept] in Kidney Transplantation, sponsored by Hoffmann-La Roche. Completed at 20 sites in United States. Open to participants aged 13 Years to 75 Years. Per ClinicalTrials.gov, last updated 2012-09-17.
Sponsored by Hoffmann-La Roche · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study will determine which, if any, allelic variants of mycophenolic acid (MPA) metabolizing enzymes, drug transporters and drug targets are associated with the observed variation in pharmacokinetic and pharmacodynamic outcomes observed with CellCept usage. Patients participating in study ML17225 will be eligible for this pharmacogenetic investigation, and will have one additional blood sample taken during the study. The anticipated time on study treatment in study ML17225 is 1-2 years, and the target sample size is 500+ individuals.
Hoffmann-La Roche is the lead sponsor of 2,102 studies on the registry; 89 are open to participants now.
Of its 331 completed or terminated interventional studies of FDA-regulated products, 248 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: mycophenolate mofetil [CellCept] · Drug: Cyclosporine or tacrolimus
Drug: mycophenolate mofetil [CellCept] · Drug: Cyclosporine or tacrolimus
Drug: mycophenolate mofetil [CellCept] · Drug: Cyclosporine or tacrolimus
Concentration-controlled
1g po bid
Drug pages: Cyclosporine · Tacrolimus
Reduced
Drug pages: Cyclosporine · Tacrolimus
Standard, as prescribed
Correlation of allelic variants of MPA metabolizing genes, membrane transporter genes and target genes with AUC, transplant rejection, GER and drug side effects.
Time frame: Throughout study
Viral kinetics
Time frame: Throughout study
The record gives a start of Dec 2005, a primary completion of Jan 2008 and a completion of Jan 2008. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Mycophenolic Acid · Cyclosporine · Tacrolimus